During treatment, 65.7% of the patients developed adverse reactions to antituberculosis drugs. Allergic reactions were most commonly associated with the use of streptomycin. The simultaneous inclusion of isoniazid, rifampicin, and pyrazinamide into the treatment regimens irrespective of the total